Phase I clinical trial - Phases précoces tumeurs solides

Phases précoces tumeurs solides
Essai clinique fermé
Public cible
An Open-Label, Multicenter, Phase 1 Study of Ramucirumab plus Pembrolizumab in Patients with Locally Advanced and Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Non-Small Cell Lung Cancer, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer.
Description de l'essai

This trial evaluates the efficacy of pembrolizumab with ramucirumab in patients with recurrent not pre-treated lung cancer.